Contract Manufacturing Services

We ask medicine makers around the world to tell us how their professional and personal lives have changed over the course of the COVID-19 crisis.

Researchers are always looking for new ways to improve effectiveness of antibody therapy.

How can companies avoid the risks of HPAPI containment and handling?

The gene and cell therapy market is growing, but does it have the CDMO support needed to maintain its upward trajectory?

A typical vaccine takes around 10 to 12 years to reach the market. A key question: “Where should we base production?”

Why drug developers should take a fresh look at long-acting dosage forms.

Nominations are now open for The Medicine Maker 2021 Power List.

How to drive antibody drug development and manufacture forward safely and quickly.

Formulation fit for the future of complex molecules.

There are ample opportunities for pharma companies to transition to greener chemical processes. Martin Hayes from Johnson Matthey tells us more.